- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/56 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
Patent holdings for IPC class A61K 47/56
Total number of patents in this class: 377
10-year publication summary
|
4
|
19
|
27
|
26
|
31
|
38
|
39
|
28
|
26
|
16
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hanmi Pharm. Co., Ltd. | 576 |
9 |
| Starpharma Pty Limited | 66 |
9 |
| Selecta Biosciences, Inc. | 190 |
6 |
| Ascendis Pharma A/S | 185 |
6 |
| Code Biotherapeutics, Inc. | 22 |
6 |
| The Regents of the University of California | 20268 |
5 |
| Massachusetts Institute of Technology | 10130 |
5 |
| Ophidion Inc. | 12 |
5 |
| Ashvattha Therapeutics, Inc. | 28 |
5 |
| The Johns Hopkins University | 5752 |
4 |
| Alnylam Pharmaceuticals, Inc. | 1138 |
4 |
| Halozyme, Inc. | 150 |
4 |
| National University Corporation Tokyo Medical and Dental University | 520 |
4 |
| University of Georgia Research Foundation, Inc. | 1046 |
4 |
| University of Maryland, Baltimore | 1038 |
4 |
| Dyne Therapeutics, Inc. | 253 |
4 |
| Barinthus Biotherapeutics North America, Inc. | 17 |
4 |
| AstraZeneca AB | 2851 |
3 |
| The Trustees of Columbia University in the City of New York | 3599 |
3 |
| Ajou University Industry-academic Cooperation Foundation | 1086 |
3 |
| Other owners | 280 |